K Dohnal

<i>PIK3CA</i> Mutations Are Associated With Lower Rates of Pathologic Complete Response to Anti–Human Epidermal Growth Factor Receptor 2 (HER2) Therapy in Primary HER2-Overexpressing Breast Cancer

Sibylle Loibl, Gϋnter von Minckwitz, Andreas Schneeweiß et al. · Journal of Clinical Oncology · 2014 · 247 citations · Full text

Clinical relevance and concordance of HER2 status in local and central testing—an analysis of 1581 HER2-positive breast carcinomas over 12 years

Berit M. Pfitzner, Bianca Lederer, Judith Lindner et al. · Modern Pathology · 2017 · 37 citations · Full text

Her2 Status, Breast Oncology, Medicine +8

Gene expression of differentiated parent in teratocarcinoma cell hybrids. Repression or reprogramming?

Jiřı́ Forejt, S Gregorová, K Dohnal et al. · Cell Differentiation · 1984 · 15 citations

Lineage Plasticity, Developmental Biology, Tumor Heterogeneity +8

Abstract S4-06: PIK3CA mutation predicts resistance to anti-HER2/chemotherapy in primary HER2-positive/hormone-receptor-positive breast cancer – Prospective analysis of 737 participants of the GeparSixto and GeparQuinto studies

Sibylle Loibl, Carsten Denkert, Andreas Schneeweis et al. · Cancer Research · 2013 · 13 citations

Breast Oncology, Phosphatidylinositol 3-Kinase, Pathology +17

Chlamydia, Gonorrhea, and HIV-1 Prevalence Among Five Populations of Women in the Czech and Slovak Republics

Katherine Kacena, K Dohnal, VERONIKA BENE OV OVA et al. · Sexually Transmitted Diseases · 2001 · 13 citations